show that global and X-chromosomal H3K27me3 reprogramming are 48 functionally separable, despite their common regulation by PRDM14. Thereby 49 we provide mechanistic insight and spatiotemporal resolution to the 50 remodeling of the epigenome during mouse PGC migration and link 51 epigenetic reprogramming to its developmental context in vivo. 52
53

INTRODUCTION 55
The germ cell lineage has the unique function of transmitting genetic and 56 epigenetic information from one generation to the next. Mammalian germ cell 57 mark from the inactive X-chromosome are perturbed, likely due to repressive 97 functions of PRDM14 on Xist and its activator Rnf12/Rlim (Ma et al., 2011; 98 germ cell lineage, how PRDM14 controls its different aspects in vivo is largely 126 unresolved: For example, it remains unknown, if PRDM14 is important for X-127 chromosome reactivation also in female PGCs, and if this is coordinated with genome-wide epigenetic changes occurring at that time. Furthermore no 129 information is available about the spatial distribution of germ cells along their 130 migration path towards the gonads during epigenetic reprogramming. To 131 address these questions, we investigated in this study epigenetic remodeling 132 of the polycomb-associated H3K27me3 mark and its dependency on 133 PRDM14 in migrating mouse PGCs. By using a whole-mount embryo staining 134 approach, we were able for the first time to collect spatiotemporal information 135 about the epigenetic reprogramming process in mouse PGCs in relation to 136 their migratory progress. We found that PRDM14 is critical both for X-137 chromosomal removal as well as global upregulation of H3K27me3 in PGCs. 138
We furthermore find differences in PRDM14-dosage dependence and kinetics 139 of X-chromosomal and global H3K27me3 changes. While both events are 140 controlled by PRDM14, they do not depend on each other and therefore must 141 be regulated through different mechanisms. In summary, we describe here 142 how PRDM14 regulates key aspects of epigenetic changes in germ cells and 143 how this is linked with progression of germ cell migration and development. To address the function of PRDM14 for PGC number and migration, we 151 immunostained whole mount embryonic day (E)9.5 mouse embryos from 152 Prdm14 +/x Prdm14 +/heterozygous crosses for AP2γ, a specific marker and 153 critical factor for PGC development (Nakaki et al., 2013a; Weber et al., 2010) . 154
We found that migrating PGCs at this stage were spread throughout the 155 hindgut, and observed in Prdm14 -/embryos a strong depletion of PGCs or 156 even their absence (7/17 embryos), when compared to wildtype and Prdm14 +/+ and Prdm14 +/embryos, while it remained low in Prdm14 -/embryos 161 ( Fig. 1B) . This is not due to a general developmental delay of Prdm14-mutant 162 embryos at E9.5, as somite numbers were similar between different Prdm14 163 genotypes ( Fig. S2A , Table S1 ). 164
In order to analyze the distribution of PGCs in more detail, we divided the 165 migration path along the hindgut into 4 quadrants (Fig. 1C) ; starting with 166 quadrant 1 (Q1) at the posterior end at the base of the allantois and finishing 167 with quadrant 4 (Q4) near the area where PGCs would exit the hindgut and 168 enter the genital ridges (future gonads). At E9.5, PGCs would be found mostly 169 in Q2 and Q3 in Prdm14 +/+ and Prdm14 +/embryos, while PGCs in Prdm14 -/-170 embryos would be located predominantly in Q1 and Q2 ( Fig. 1D, S2B ). This 171
indicates that Prdm14-mutant PGCs might be delayed in migration, although 172 few of them can be also found in Q3 and Q4. In summary, Prdm14-mutant 173 embryos show a strong reduction in PGC-numbers and a defect in PGC 174 migration. 175 176 PRDM14 is required for global upregulation of H3K27me3 in migrating 177
PGCs 178
As PRDM14 has a role in the global epigenetic reprogramming occurring in 179
PGCs (Yamaji et al., 2008) , we wanted to investigate in more detail its 180 function for upregulating the H3K27me3 mark, which is a hallmark of 181 migrating PGCs (Hajkova et al., 2008; Seki et al., 2005; Seki et al., 2007) . We 182 therefore costained E9.5 embryos of different Prdm14 genotypes with AP2γ 183 and H3K27me3 antibodies ( Fig. 2A ). We scored H3K27me3 as being 184 upregulated or non-upregulated in AP2γ-positive PGCs when compared to 185 surrounding somatic cells. It thereby became apparent that H3K27me3 186 upregulation was in direct relation to PRDM14 dosage, as about 78% of 187 wildtype PGCs had elevated H3K27me3 staining, while only 54% of 188 heterozygote and only 19% of Prdm14-null PGCs did ( Fig. 2B , Table S1 ). 189
These differences were observed to a similar degree both in male and in 190 female embryos, indicating that PRDM14 controlled global H3K27me3 levels 191 in a sex-independent manner.
When we assessed H3K27me3 upregulation in relation to developmental 193 progression (somite number) at E9.5, we observed that H3K27me3 increased 194 with somite number in Prdm14 +/+ and Prdm14 +/-, but not in Prdm14 -/embryos 195 ( Fig. 2C ). Interestingly, H3K27me3 levels did not seem to vastly change in 196
PGCs within different quadrants of their migration path, indicating that global 197
H3K27me3 upregulation depends more on overall developmental progression 198 of the embryo than on the position of the PGCs along the hindgut (Fig. S3 ). 199
Overall, we conclude that global H3K27me3 upregulation in PGCs is H3K27me3 and its associated enzymatic complex, PRC2, are strongly 231 enriched on the inactive X-chromosome in female cells. Therefore, we 232 hypothesized, if this could act as a "sink" for PRC2, whereby global 233 upregulation of H3K27me3 in PGCs would require first stripping PRC2 off the 234 X-chromosome through XCR to make it available for acting elsewhere in the 235 genome. In order to test this hypothesis, we investigated the relationship 236 between X-chromosomal downregulation and global upregulation of 237
H3K27me3 in female PGCs (Fig. 4, S5 ). If the inactive X were acting as a sink 238 for PRC2, we would expect global H3K27me3 not to be upregulated in PGCs 239
harboring an X-spot. However, when comparing within the different genotypes 240 the fraction of PGCs which have lost or retained the X-chromosomal 241
H3K27me3-spot, we did not detect any significant differences in global 242
H3K27me3 upregulation (Fig. 4A ). This indicates that losing the X-spot is not 243 a general prerequisite for global H3K27me3 upregulation in female PGCs. 244
Also the fact that Prdm14 +/+ and Prdm14 +/-PGCs showed almost identical X-245 spot loss (52% in +/+ vs. 51% in +/-) but different global H3K27me3 246 upregulation levels (75% in +/+ vs. 56% in +/-), indicates that X-spot loss and 247 global H3K27me3 upregulation are independent epigenetic events. In 248 conclusion, while PRDM14 is both required for normal X-chromosomal and 249 global H3K27me3 reprogramming in PGCs (Fig. 4B, S6 ), these events are 250 mechanistically separable and do not depend on each other. 251 252
Summary and discussion 253
In this study, we have investigated the role of PRDM14 during epigenetic 254 reprogramming in migrating mouse PGCs (summarized in Fig. 4B, S6 ). We 255 thereby have uncovered multiple roles for PRDM14 during germ cell development. Most importantly, we have identified PRDM14 to our knowledge 257 as the first factor with functional importance for XCR in the germ cell lineage. 258
In particular, we found that erasure of H3K27me3 mark from the inactive X-259 chromosome, a key step during X-reactivation (Borensztein et al., 2017; 260 Chuva de Sousa Lopes et al., 2008; de Napoles et al., 2007; Mak et al., 261 2004) , occurred progressively during the migration of female PGCs and 262 required PRDM14. This observation is in line with the role of PRDM14 during 263 X-reactivation in the mouse blastocyst and during iPSC-reprogramming 264 (Payer et al., 2013) . 265
Second, we uncovered that global H3K27me3 upregulation in PGCs is 266 dependent on PRDM14 in a dosage-sensitive manner, as Prdm14 +/and 267
Prdm14 -/-PGCs showed a progressive defect. Interestingly, we observed that 268
H3K27me3 upregulation seemed to mostly depend on the developmental 269 stage of the embryo rather than the PGC position along the migratory path, 270 which is in contrast to the kinetics of X-specific H3K27me3 removal. 271
Another key finding from our study is that the global upregulation and X- suggested that PRDM14 could directly interact with the PRC2 complex in 285 pluripotent stem cells and thereby facilitate its recruitment to PRDM14 target 286 genes (Chan et al., 2013; Yamaji et al., 2013) or that PRDM14 could activate studies however challenged this view and proposed that PRDM14 mainly acts 289 though its binding partner and co-repressor CBFA2T2/MTGR1 (Kawaguchi et 290 al., 2019; Nady et al., 2015; Tu et al., 2016) , suggesting that PRC2 might be 291 recruited secondarily to PRDM14 targets. Regarding its X-chromosome-292 specific role, we have previously shown that PRDM14 binds to regulatory and a delay in PGC migration. This is in line with a recent study (Cheetham et 309 al., 2018) , which found that genes implicated in cell migration are bound by 310 PRDM14 in PGC-like cells derived in vitro, suggesting that PRDM14 might be 311 directly involved in controlling PGC migration. 312
In summary, here we have shown that autosomal and X-chromosomal 313 reprogramming of H3K27me3 occur independently during PGC migration, but 314 that they rely both on the key germ cell factor PRDM14. By adding to our 315 understanding of the mechanisms underlying epigenetic changes required for 316 germ cell development in vivo, we provide a framework for assessing and
MATERIALS AND METHODS 321 322
Embryo isolation 323
Mouse care and procedures were conducted according to the protocols 324 approved by the Ethics Committee on Animal Research of the Parc de 325
Recerca Biomèdica de Barcelona (PRBB) and by the Departament de 326
Territori i Sostenibilitat of the Generalitat de Catalunya. 327
Prdm14 mutant mice (Yamaji et al., 2008) were maintained in a predominant 328 C57BL/6 strain background. Prdm14 heterozygous mice were mated and 329 resulting embryos were harvested from pregnant females at E9.5 and 330 dissected from maternal tissues. 331
Whole mount immunostaining 333
The whole mount embryo immunostaining was performed as described in 334 (Yamaji et al., 2008) . The primary antibodies used were rabbit polyclonal anti-335 After the immunostaining, the somite number of every embryo was counted 341 under the stereomicroscope. Then the embryo was split in two parts: the head 342 was used for genotyping and the hindgut was dissected and mounted in 343 
